Single answer
Is Artelo Biosciences Inc (ARTL) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Artelo Biosciences Inc a clinical stage biopharmaceutical company focuses on developing and commercializing treatments to modulate the endocannabinoid system Its product candidate pipeline includes ART2713 a synthetic G proteincoupled receptor agonist which is in Phase 1b2a clinical trial for the treatment of anorexia associated with cancer ART1211 a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and posttraumatic stress disorder PTSD and ART2612 a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment as well as for treating PTSD Artelo Biosciences Inc has research collaboration with Trinity College Dublin to investigate ART2713 for the treatment of cancer cachexia The company was formerly known as Reactive Medical Inc and changed its name to Artelo Biosciences Inc in April 2017 Artelo Biosciences Inc was incorporated in 2011 and is based in Solana Beach California
Website: https://www.artelobio.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.22. Cash flow to debt ratio: -8.57. Net profit margin: 0.00%. Inflation risk score: high (0.75/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
No, the average daily trading liquidity for Artelo Biosciences Inc is $945,491. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
We cannot find data for Artelo Biosciences Inc 10 years ago, but if you had invested on 2019-06-21 when the price was $69.75, you would have made a loss of $68.59 per share or 98.34%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.